JYNT (The Joint) Other Financing: $-0.02 Mil (TTM As of Mar. 2026)


JYNT The Joint Corp JYNT
63 GF Score
Price $8.52
GF Value $11.11
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is The Joint Other Financing?

The Joint JYNT -7.49% 63 Other Financing is $-0.02 Mil as of Mar. 2026. GuruFocus rates JYNT with a GF Score™ of 63/100 and a GF Value™ of $11.11 (Modestly Undervalued). The stock has 4 warning signs investors should review.

The Joint's Other Financing for the three months ended in Mar. 2026 was $-0.02 Mil.

The Joint's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.02 Mil.

The Joint Other Financing Historical Data

* Premium members only.

The historical data trend for The Joint's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Joint Other Financing Chart

The Joint Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.81 0.38 0.20 0.02 1.51

The Joint Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.90 0.00 0.00 0.00 -0.02
JYNT
63GF Score
The Joint Corp JYNT
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Joint Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $-0.02 Mil mean?
The Joint (JYNT) has a Other Financing of $-0.02 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for The Joint and its competitors.
Is The Joint's Other Financing too high?
The Joint's current Other Financing is $-0.02 Mil. Overall, The Joint has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Joint's Other Financing compare to MAHN and WW?
The Joint's Other Financing of $-0.02 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Healthcare Providers & Services company?
A good Other Financing depends on the Healthcare Providers & Services industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for The Joint and its competitors. The Joint's current Other Financing is $-0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Joint stock overvalued right now?
Based on GuruFocus' analysis, The Joint (JYNT) is currently considered Modestly Undervalued. The stock's GF Value™ is $11.11, compared to a current price of $8.52 — trading 23.3% below its estimated fair value. The current Other Financing is $-0.02 Mil. The Joint's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For The Joint (JYNT), the current Other Financing is $-0.02 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is The Joint (JYNT) Overvalued in 2026?

Based on GuruFocus' analysis, The Joint stock appears to be undervalued. The current stock price of $8.52 is trading 23.3% below its estimated GF Value™ of $11.11. GuruFocus considers The Joint to be Modestly Undervalued.

Key valuation signals for JYNT:

  • Other Financing: $-0.02 Mil
  • GF Value™: $11.11 vs. price of $8.52 (23.3% below fair value)
  • GF Score™: 63/100 with 4 warning signs

No single metric tells the full story. See the JYNT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

The Joint Business Description

Address 16767 North Perimeter Drive, Suite 110, Scottsdale, AZ, USA, 85260
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.
63GF Score

Get the complete analysis for JYNT

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.52
Price
$11.11
GF Value